Gyre Therapeutics, Inc. GYRE Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: Gyre Therapeutics, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s change in other liabilities?
- Gyre Therapeutics, Inc. (GYRE) reported change in other liabilities of -$11.75K in Q4 2025.
- How has Gyre Therapeutics, Inc.'s change in other liabilities changed year-over-year?
- Gyre Therapeutics, Inc.'s change in other liabilities decreased by 145.2% year-over-year, from $26K to -$11.75K.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.